Skip to main content

Table 4 Outcomes of patients recruited for this study

From: Safety of intravenous administration of hydrogen-enriched fluid in patients with acute cerebral ischemia: initial clinical studies

 

Total (n = 38)

G I (n = 27)

G II (n = 11)

7 d after admission

30 d after admission

90 d after admission

7 d after admission

30 d after admission

90 d after admission

7 d after admission

30 d after admission

90 d after admission

NIHSS score, mean

5.6 ± 7.1

4.9 ± 6.5

4.5 ± 6.3

7.2 ± 7.8

6.4 ± 7.2

6.0 ± 6.9

1.8 ± 1.1

1.4 ± 1.6

1.1 ± 1.4

mRS, n (%)

    
 

4-6

15 (39.5)

15 (39.5)

13 (34.2)

14 (51.8)

13 (48.1)

12 (44.4)

1 (9.1)

2 (18.2)

1 (9.1)

 

Death

1 (2.6)

1 (2.6)

1 (2.6)

1 (3.7)

1 (3.7)

1 (3.7)

0 (0)

0 (0)

0 (0)

Barthel index, mean

63.8 ± 39.8

67.6 ± 40.3

69.3 ± 39.8

55 ± 42.9

58.3 ± 43.2

59.6 ± 42.8

84.5 ± 19.0

89.5 ± 19.4

92.3 ± 15.9

Patients with t-PA infusion

   
  

n = 11

n = 10

n = 1

Early recanalization, n (%)

4 (36.4)

4 (40)

0 (0)

 

Complete

1 (9.1)

1 (10)

0 (0)

 

Partial

3 (27.3)

3 (30)

0 (0)

Hemorrhagic transformation, n (%)

2 (18.2)

2 (20)

0 (0)

Symptomatic, n (%)

0 (0)

0 (0)

0 (0)